These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 21538707)

  • 1. Conformational constraints in angiotensin IV to probe the role of Tyr², Pro⁵ and Phe⁶.
    Lukaszuk A; Demaegdt H; Van den Eynde I; Vanderheyden P; Vauquelin G; Tourwé D
    J Pept Sci; 2011 Aug; 17(8):545-53. PubMed ID: 21538707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The replacement of His(4) in angiotensin IV by conformationally constrained residues provides highly potent and selective analogues.
    Lukaszuk A; Demaegdt H; Feytens D; Vanderheyden P; Vauquelin G; Tourwé D
    J Med Chem; 2009 Sep; 52(18):5612-8. PubMed ID: 19757839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-homo-amino acid scan of angiotensin IV.
    Lukaszuk A; Demaegdt H; Szemenyei E; Tóth G; Tymecka D; Misicka A; Karoyan P; Vanderheyden P; Vauquelin G; Tourwé D
    J Med Chem; 2008 Apr; 51(7):2291-6. PubMed ID: 18386881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disulfide cyclized tripeptide analogues of angiotensin IV as potent and selective inhibitors of insulin-regulated aminopeptidase (IRAP).
    Andersson H; Demaegdt H; Vauquelin G; Lindeberg G; Karlén A; Hallberg M; Erdélyi M; Hallberg A
    J Med Chem; 2010 Nov; 53(22):8059-71. PubMed ID: 21047126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligands to the (IRAP)/AT4 receptor encompassing a 4-hydroxydiphenylmethane scaffold replacing Tyr2.
    Andersson H; Demaegdt H; Vauquelin G; Lindeberg G; Karlén A; Hallberg M
    Bioorg Med Chem; 2008 Jul; 16(14):6924-35. PubMed ID: 18556208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent macrocyclic inhibitors of insulin-regulated aminopeptidase (IRAP) by olefin ring-closing metathesis.
    Andersson H; Demaegdt H; Johnsson A; Vauquelin G; Lindeberg G; Hallberg M; Erdelyi M; Karlen A; Hallberg A
    J Med Chem; 2011 Jun; 54(11):3779-92. PubMed ID: 21476495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small potent ligands to the insulin-regulated aminopeptidase (IRAP)/AT(4) receptor.
    Axén A; Andersson H; Lindeberg G; Rönnholm H; Kortesmaa J; Demaegdt H; Vauquelin G; Karlén A; Hallberg M
    J Pept Sci; 2007 Jul; 13(7):434-44. PubMed ID: 17559064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic insulin-regulated aminopeptidase (IRAP)/AT4 receptor ligands.
    Axén A; Lindeberg G; Demaegdt H; Vauquelin G; Karlén A; Hallberg M
    J Pept Sci; 2006 Nov; 12(11):705-13. PubMed ID: 16967438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin IV displays only low affinity for native insulin-regulated aminopeptidase (IRAP).
    Demaegdt H; De Backer JP; Lukaszuk A; Tóth G; Szemenyei E; Tourwé D; Vauquelin G
    Fundam Clin Pharmacol; 2012 Apr; 26(2):194-7. PubMed ID: 21477268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase.
    Lee J; Mustafa T; McDowall SG; Mendelsohn FA; Brennan M; Lew RA; Albiston AL; Chai SY
    J Pharmacol Exp Ther; 2003 Apr; 305(1):205-11. PubMed ID: 12649370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the substitution of Phe4 in the opioid peptide [D-Ala8]dynorphin A-(1-11)NH2.
    Vig BS; Zheng MQ; Murray TF; Aldrich JV
    J Med Chem; 2003 Sep; 46(19):4002-8. PubMed ID: 12954053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective labeling of IRAP by the tritiated AT(4) receptor ligand [3H]Angiotensin IV and its stable analog [3H]AL-11.
    Demaegdt H; Lukaszuk A; De Buyser E; De Backer JP; Szemenyei E; Tóth G; Chakravarthy S; Panicker M; Michotte Y; Tourwé D; Vauquelin G
    Mol Cell Endocrinol; 2009 Nov; 311(1-2):77-86. PubMed ID: 19643163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local control of peptide conformation: stabilization of cis proline peptide bonds by aromatic proline interactions.
    Wu WJ; Raleigh DP
    Biopolymers; 1998 Apr; 45(5):381-94. PubMed ID: 9530015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin AT4 receptor ligand interaction with cystinyl aminopeptidase and aminopeptidase N: [125I]Angiotensin IV only binds to the cystinyl aminopeptidase apo-enzyme.
    Demaegdt H; Lenaerts PJ; Swales J; De Backer JP; Laeremans H; Le MT; Kersemans K; Vogel LK; Michotte Y; Vanderheyden P; Vauquelin G
    Eur J Pharmacol; 2006 Sep; 546(1-3):19-27. PubMed ID: 16919623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]IVDE77, a novel radioligand with high affinity and selectivity for the insulin-regulated aminopeptidase.
    Nikolaou A; Van den Eynde I; Tourwé D; Vauquelin G; Tóth G; Mallareddy JR; Poglitsch M; Van Ginderachter JA; Vanderheyden PM
    Eur J Pharmacol; 2013 Feb; 702(1-3):93-102. PubMed ID: 23376157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformationally constrained formyl methionyl tripeptides: structure-function study of analogs containing alpha,beta-dehydrophenylalanine and dehydroleucine.
    Bharadwaj A; Singh M; Bhandary K; Becker EL; Chauhan VS
    Pept Res; 1993; 6(6):298-307. PubMed ID: 8292847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of "AT4 receptor" ligands to insulin regulated aminopeptidase (IRAP) in intact Chinese hamster ovary cells.
    Demaegdt H; Gard P; De Backer JP; Lukaszuk A; Szemenyei E; Tóth G; Tourwé D; Vauquelin G
    Mol Cell Endocrinol; 2011 Jun; 339(1-2):34-44. PubMed ID: 21457753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.
    Erchegyi J; Penke B; Simon L; Michaelson S; Wenger S; Waser B; Cescato R; Schaer JC; Reubi JC; Rivier J
    J Med Chem; 2003 Dec; 46(26):5587-96. PubMed ID: 14667213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
    Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
    J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.